Immunogenicity 15712
Sample ID
3713
Response
Positive
Tumor Type
Melanoma
Gene Symbol
TPX2
Transcript ID
None
HLA INFO
B*44:03
TCR INFO
No TCR info found!
Full length protein sequence (747 aa)
MSQVK
1
SSYSY
6
DAPSD
11
FINFS
16
SLDDE
21
GDTQN
26
IDSWF
31
EEKAN
36
LENKL
41
LGKNG
46
TGGLF
51
QGKTP
56
LRKAN
61
LQQAI
66
VTPLK
71
PVDNT
76
YYKEA
81
EKENL
86
VEQSI
91
PSNAC
96
SSLEV
101
EAAIS
106
RKTPA
111
QPQRR
116
SLRLS
121
AQKDL
126
EQKEK
131
HHVKM
136
KAKRC
141
ATPVI
146
IDEIL
151
PSKKM
156
KVSNN
161
KKKPE
166
EEGSA
171
HQDTA
176
EKNAS
181
SPEKA
186
KGRHT
191
VPCMP
196
PAKQK
201
FLKST
206
EEQEL
211
EKSMK
216
MQQEV
221
VEMRK
226
KNEEF
231
KKLAL
236
AGIGQ
241
PVKKS
246
VSQVT
251
KSVDF
256
HFRTD
261
ERIKQ
266
HPKNQ
271
EEYKE
276
VNFTS
281
ELRKH
286
PSSPA
291
RVTKG
296
CTIVK
301
PFNLS
306
QGKKR
311
TFDET
316
VSTYV
321
PLAQQ
326
VEDFH
331
KRTPN
336
RYHLR
341
SKKDD
346
INLLP
351
SKSSV
356
TKICR
361
DPQTP
366
VLQTK
371
HRARA
376
VTCKS
381
TAELE
386
AEELE
391
KLQQY
396
KFKAR
401
ELDPR
406
ILEGG
411
PILPK
416
KPPVK
421
PPTEP
426
IGFDL
431
EIEKR
436
IQERE
441
SKKKT
446
EDEHF
451
EFHSR
456
PCPTK
461
ILEDV
466
VGVPE
471
KKVLP
476
ITVPK
481
SPAFA
486
LKNRI
491
RMPTK
496
EDEEE
501
DEPVV
506
IKAQP
511
VPHYG
516
VPFKP
521
QIPEA
526
RTVEI
531
CPFSF
536
DSRDK
541
ERQLQ
546
KEKKI
551
KELQK
556
GEVPK
561
FKALP
566
LPHFD
571
TINLP
576
EKKVK
581
NVTQI
586
EPFCL
591
ETDRR
596
GALKA
601
QTWKH
606
QLEEE
611
LRQQK
616
EAACF
621
KARPN
626
TVISQ
631
EPFVP
636
KKEKK
641
SVAEG
646
LSGSL
651
VQEPF
656
QLATE
661
KRAKE
666
RQELE
671
KRMAE
676
VEAQK
681
AQQLE
686
EARLQ
691
EEEQK
696
KEELA
701
RLRRE
706
LVHKA
711
NPIRK
716
YQGLE
721
IKSSD
726
QPLTV
731
PVSPK
736
FSTRF
741
HC
746
Mutation Information
DNA mutation:
None
Peptide Range:
450 ~ 458
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"TEDEHFEFH
||||||||.
Mutant:
TEDEHFEFY"
Cancer Immunol Res, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensGene Name (from Reference) TPX2
Checkpoint
Blockade
None
ACT
Y
Vaccination
N
Curative
Effect
durable regression
minimal_peptide
Y
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
B cells
Assay
None